LGG-40. Growth hormone replacement in children on therapy with Vemurafenib for Low Grade Glioma

BRAF inhibitors (iBRAF) are a therapeutical option for pediatric Low-Grade-Gliomas (pLGG), but their chronic use may be needed to prevent tumor regrowth. Growth hormone (GH) replacement in children with GH deficiency (GHD) and on oncological treatment is under debate. We report on our experience of...

Descripción completa

Detalles Bibliográficos
Autores principales: Verrico, Antonio, Crocco, Marco, Casalini, Emilio, Ramaglia, Antonia, Rossi, Andrea, Iurilli, Valentina, Piccolo, Gianluca, Milanaccio, Claudia, Garrè, Maria Luisa, Iorgi, Natascia Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Low Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164719/
http://dx.doi.org/10.1093/neuonc/noac079.352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164719/
http://dx.doi.org/10.1093/neuonc/noac079.352

Ejemplares similares